Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of central nervous system (CNS) agents. Its structure allows for selective modifications, making it valuable in creating bioactive molecules such as receptor agonists or antagonists. Commonly employed in medicinal chemistry for constructing piperidine-based drug candidates, especially in treatments targeting neurological disorders, including depression, anxiety, and psychosis. Also utilized in the preparation of kinase inhibitors and other targeted therapies in oncology research. The presence of bromo and fluoro substituents enables further functionalization through cross-coupling reactions, enhancing its utility in structure-activity relationship (SAR) studies.